Oncology program advancing with data expected in the fourth quarter 2025BEACON-IPF close out activities to be completed in ...

The investigators also reported that LTI-03 helped preserve alveolar epithelial type II (AT2) progenitor cells, which are essential for lung repair and regeneration. Current IPF therapies primarily ...

During the third quarter, our team continued to advance our portfolio while winding down activities surrounding the BEACON-IPF trial,” said ...

For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC), ...

A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Gersten: I've ...

US-based patients with idiopathic pulmonary fibrosis (IPF) had a slower decline in forced vital capacity (FVC) when they received nerandomilast (Jascayd; Boehringer Ingelheim) compared with placebo, a ...

The news of Diane Ladd’s death at 89 has brought attention to a rare but serious lung condition. The legendary actress, known ...

Please provide your email address to receive an email when new articles are posted on . Saracatinib appeared to be “equal or superior” in stopping fibrotic responses compared with two FDA-approved ...

Main objectives: prolong business development and partnership efforts for Imeglimine, PXL770, and PXL065; ensure the ...